Geron reported $46.63M in Current Liabilities for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Amgen AMGN:US $ 12886M 702M
Bio Techne TECH:US $ 166.84M 12.03M
Cti Biopharma CTIC:US $ 98.93M 32.28M
Cytokinetics CYTK:US $ 66.85M 5.01M
Esperion Therapeutics ESPR:US $ 79.08M 5.73M
Exelixis EXEL:US $ 289.08M 48.51M
Genmab GEN:DC DK 1339M 229M
Geron GERN:US $ 46.63M 1.11M
Gilead Sciences GILD:US $ 8558M 3052M
Macrogenics MGNX:US $ 67.1M 7.48M
Novartis NOVN:VX SF 29807M 401M
Novavax NVAX:US $ 2261M 129.31M
Pain Therapeutics PTIE:US $ 6.79M 5.74M
Seattle Genetics SGEN:US $ 531.29M 37.56M
YTE INCY:US $ 886.16M 31.86M